Solesence Earnings Call Transcripts
Fiscal Year 2025
-
Revenue hit a record $62.1M in 2025, up 18.6% year-over-year, but margin compression limited profit growth. Operational improvements and the Transform and Transcend initiative aim to boost margins and EBITDA in 2026, with a 30% gross margin floor set.
-
Q3 2025 saw a 14% revenue decline and a net loss, impacted by industry softness and operational inefficiencies, but full-year sales are up $10–12 million. Leadership changes, cost controls, and facility consolidation are expected to restore margins and drive future growth, with guidance for improved profitability and continued outperformance in mineral-based beauty.
-
Record Q2 revenue and profitability were driven by strong demand, operational efficiencies, and new partnerships. Despite expected demand moderation in the second half due to tariffs and seasonality, full-year revenue is projected to reach a new high.
-
Record Q1 revenue grew nearly 50% year-over-year, driven by major product launches and strong demand, though margins were temporarily impacted by one-time startup costs. Gross margins are expected to rebound above 30% for the year, with continued top-line growth and operational improvements underway.
Fiscal Year 2024
-
Record 2024 revenue and net income were driven by strong demand, margin expansion, and operational improvements. Outlook for 2025 remains positive, with continued growth, new product launches, and Nasdaq uplisting plans, though risks from tariffs and inventory management persist.
-
Q3 2024 saw record revenue and a dramatic swing to profitability, with strong gross margins and robust order growth. Operational improvements and expanded capacity support a positive outlook, with 2024 revenue expected to exceed $50 million and continued double-digit growth into 2025.
-
Q2 2024 saw 32% sequential and 10% year-over-year revenue growth, with net income swinging to $900,000. The company expects second-half revenue to exceed the first, targeting over $50 million for the year and gross margins in the 35%-40% range, driven by Solesence demand.